| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 01/03/2013 | WO2013001244A1 Polymer particles or nano-vectors and use thereof as a drug and/or diagnostic agent |
| 01/03/2013 | WO2013000970A1 Bis tridentate w3o2 clusters for x-ray imaging |
| 01/03/2013 | WO2012155076A3 Imaging contrast agents and uses thereof |
| 01/03/2013 | WO2012151539A3 Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof |
| 01/03/2013 | WO2012131104A3 Biodegradable compositions suitable for controlled release |
| 01/03/2013 | WO2012107760A3 Layered bodies, compositions containing them and processes for producing them |
| 01/03/2013 | WO2012094620A9 Hydrophobic molecule-induced branched polymer aggregates and their use |
| 01/03/2013 | WO2011141705A8 Novel cationic lipids and methods of use thereof |
| 01/03/2013 | US20130006094 Systems, methods, compositions and devices for in vivo magnetic resonance imaging of lungs using perfluorinated gas mixtures |
| 01/03/2013 | US20130004433 Preparation of stabilised x-ray diagnostic composition |
| 01/03/2013 | US20130004432 Monoclonal antibodies that bind b7h6 and uses thereof |
| 01/03/2013 | US20130004431 Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof |
| 01/03/2013 | US20130004430 Fluorescent photoprobe for the imaging of endothelin receptors |
| 01/03/2013 | US20130004429 Use of a neurofilament peptide for the treatment of glioma |
| 01/03/2013 | US20130004427 Targeted dendrimer-drug conjugates |
| 01/03/2013 | US20130004426 Adenosine derivative formulations for medical imaging |
| 01/03/2013 | US20130004425 Biomineral and Metal Binding Liposomes, Their Synthesis, and Methods of Use Thereof |
| 01/03/2013 | US20130004424 Methods for determining agents targeting mena isoforms and uses thereof for diagnosis and treatment of metastatic tumors |
| 01/03/2013 | US20130004423 Polyazamacrocyclic compound, and a production method and a biomedical use therefor |
| 01/03/2013 | US20130004419 Carbonylporphyrins and Uses Thereof |
| 01/03/2013 | US20130004416 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 01/02/2013 | EP2540322A1 Ultrasonic couplant spray |
| 01/02/2013 | EP2540321A1 Bis Tridentate W3O2 Clusters for X-Ray imaging |
| 01/02/2013 | EP2540282A2 Surface-modified tantalum oxide nanoparticles, preparation method thereof, and contrast medium for x-ray computed tomography and highly dielectric thin film using same |
| 01/02/2013 | CN1854157B Antibodies to insulin-like growth factor i receptor |
| 01/02/2013 | CN1551781B One dose vaccination with mycoplasma hyopneumoniae |
| 01/02/2013 | CN102858794A Peptides whose uptake in cells is controllable |
| 01/02/2013 | CN102858377A Hyperpolarized lactate contrast agent for determination of LDH activity |
| 01/02/2013 | CN102858367A Composite body for antigen or drug delivery |
| 01/02/2013 | CN102850599A Magnetic chitosan/nano Fe3O4 composite and preparation method and application thereof |
| 01/02/2013 | CN102284067B Fluorescent molecular image probe and magnetic/fluorescent bimodal molecular image probe and preparation method thereof |
| 01/02/2013 | CN102242081B Super paramagnetic iron oxide particle marked cell for magnetic-resonance tracing in vivo |
| 01/02/2013 | CN102145183B Method for preparing nanogate carbon suspension |
| 01/02/2013 | CN102065906B Methods for radiolabelling macromolecules |
| 01/02/2013 | CN102049052B Method for preparing monodispersed and uniform single core-supported silicon oxide-wrapped hydrophobic nanocrystalline |
| 01/02/2013 | CN101881760B Method for measuring toxic hazard effect of toxic chemical |
| 01/02/2013 | CN101824090B Monoclonal antibody hpam4 |
| 01/01/2013 | US8343462 Formulations for use in medical and diagnostic procedures |
| 01/01/2013 | US8343461 Molecular signature of cancer |
| 01/01/2013 | US8343457 Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
| 12/27/2012 | WO2012177701A2 Compositions, methods of synthesis and use of carbohydrate targeted agents |
| 12/27/2012 | WO2012177088A1 Surface treatment method for magnetic particles, magnetic composite prepared thereby, and magnetic composite for labeling target materials |
| 12/27/2012 | WO2012177039A2 Mri contrast agent for lymphography based on iron oxide nanoparticles and method for imaging lymph node using the same |
| 12/27/2012 | WO2012175702A1 Rimfampicin analogue useful for infection imaging |
| 12/27/2012 | WO2012175223A1 Cathepsin-binding compounds bound to a carrier and their diagnostic use |
| 12/27/2012 | WO2012128504A3 Uridine-based gadolinium complex and mri contrast agent comprising same |
| 12/27/2012 | WO2012124998A3 Bio-pin |
| 12/27/2012 | WO2012031250A3 Compositions for labeling nerves and methods of use |
| 12/27/2012 | US20120330153 Subcutaneous cavity marking device and method |
| 12/27/2012 | US20120328530 Toluidine blue derivatives as photosensitising compounds |
| 12/27/2012 | US20120328529 Microfluidic-based generation of functionalized microbubbles for ultrasound imaging and therapy |
| 12/27/2012 | US20120328528 Monoclonal antibody against necrosis marker prdx4 and use thereof |
| 12/27/2012 | US20120328527 Methods of enhancing functioning of the large intestine |
| 12/27/2012 | US20120328526 Modulation of Nad+ Activity in Neuropathophysiological Conditions and Uses Thereof |
| 12/27/2012 | US20120328525 Nanoparticle compositions and components thereof |
| 12/27/2012 | US20120328524 Anti-gd2 antibodies and methods and uses related thereto |
| 12/27/2012 | US20120328523 Polyhydroxyalkanoates for in vivo applications |
| 12/27/2012 | US20120328522 Diagnostic composition comprising plasma cations having superior safety profile |
| 12/27/2012 | US20120328520 Conjugate with target-finding ligand and use thereof |
| 12/27/2012 | US20120328519 Dentric polyglycerol sulfates and sulfonates and their use for inflammatory diseases |
| 12/27/2012 | US20120328515 In vivo detection of apoptosis |
| 12/27/2012 | US20120328514 N-alkoxyamide conjugates as imaging agents |
| 12/27/2012 | US20120328512 Fibrin-Binding Peptides and Conjugates Thereof |
| 12/27/2012 | CA2843313A1 Compositions, methods of synthesis and use of carbohydrate targeted agents |
| 12/27/2012 | CA2827752A1 Mri contrast agent for lymphography based on iron oxide nanoparticles and method for imaging lymph node using the same |
| 12/26/2012 | EP2537834A2 Polyazamacrocyclic compound, and a production method and a biomedical use therefor |
| 12/26/2012 | EP2537532A1 Cathepsin-binding compounds bound to a nanodevice and their diagnostic and therapeutic use |
| 12/26/2012 | EP2536712A1 Oligothiophene derivate as molecular probes |
| 12/26/2012 | EP2536691A1 Bifunctional chelating agents |
| 12/26/2012 | EP2536437A2 Infiltration solution for treating an enamel lesion |
| 12/26/2012 | CN102836446A In-vivo phase transition tumor targeted nanobubble, its preparation method and application |
| 12/26/2012 | CN102836445A Method for quickly preparing model of animal such as dog with portal hypertension |
| 12/26/2012 | CN102836444A Composite reagent for fast preparation of portal hypertension animal models and preparation process |
| 12/26/2012 | CN102836443A Polypeptide-modified brain-targeted nanometer device and preparation method and usage thereof |
| 12/26/2012 | CN102836438A Multi-component biological transport systems |
| 12/26/2012 | CN102836433A Sensitizing agent used for reversing or reducing esophageal cancer radiotherapy resistance, screening method thereof, and purpose thereof |
| 12/26/2012 | CN102836429A Antibody-based targeting medicine used for repairing damaged tissues, administration method, and magnetic resonance imaging contrast agent |
| 12/26/2012 | CN102836292A Research method for effect of extracts of modified five-ingredient toxin-dispersing beverage to carrageenan-induced inflammation in mice |
| 12/26/2012 | CN101643645B Calcium phosphate material marked by fluorescein isothiocyanate and preparation method thereof |
| 12/25/2012 | US8338602 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids |
| 12/25/2012 | US8338362 Methods for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity |
| 12/25/2012 | US8337812 Regulator of ephrin-Eph receptor signaling and mouse having abnormal ephrin-Eph receptor signaling mechanisms |
| 12/20/2012 | WO2012174285A2 Inhibitor probes for imaging sodium-glucose cotransporters in health and disease |
| 12/20/2012 | WO2012174049A2 Compositions and methods for controlling neuronal excitation |
| 12/20/2012 | WO2012173933A2 Activatable nanoprobes for intracellular drug delivery |
| 12/20/2012 | WO2012173288A1 Magnetic resonance imaging t2 contrast medium for cell contrasting, and method for manufacturing same |
| 12/20/2012 | WO2012173003A2 Medical tissue-marker and manufacturing method for same |
| 12/20/2012 | WO2012172457A1 Novel lipidomimetic compounds and uses thereof |
| 12/20/2012 | WO2012142138A3 Cuinse/zns nir-quantum dots (qds) for biomedical imaging |
| 12/20/2012 | WO2012136958A3 Optical imaging probes |
| 12/20/2012 | US20120324593 Lysyl Oxidase-Like 1 (LOXL1) and Elastogenesis |
| 12/20/2012 | US20120321564 Compositions Useful for Reducing Nephrotoxicity and Methods of Use Thereof |
| 12/20/2012 | US20120321563 Carbonic Anhydrase Targeting Agents and Methods of Using Same |
| 12/20/2012 | US20120321562 Nicotinic acid and picolinic acid derived near-infrared fluorophores |
| 12/20/2012 | US20120321561 Cancer diagnosis and imaging |
| 12/20/2012 | US20120321555 Treatment and prophylaxis of amyloidosis |
| 12/20/2012 | CA2839200A1 Medical tissue-marker and manufacturing method for same |
| 12/20/2012 | CA2839063A1 Activatable nanoprobes for intracellular drug delivery |
| 12/19/2012 | CN102827228A Silicon phthalocyanine modified by cytidine derivative and preparation method and application thereof |
| 12/19/2012 | CN102824648A Multipurpose contrast agent applied to ultrasonography/magnetic resonance imaging (US/MRI) guidance synergistic high-intensity focused ultrasound ablation and preparation method for multipurpose contrast agent |